OncoImmunology
Volume 10, 2021 - Issue 1
Open access
2,548
Views
2
CrossRef citations to date
0
Altmetric
Research Article
An Open–Label, Randomized, Multi–Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin–2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma
Merve Hasanova Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas Md Anderson Cancer Center, Houston, USAhttps://orcid.org/0000-0002-6102-4917View further author information
, Denái R. Miltonb Department of Biostatistics, The University of Texas Md Anderson Cancer Center, Houston, USAView further author information
, William H. Sharfmanc Department of Medical Oncology and Dermatology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Lutherville, USAhttps://orcid.org/0000-0001-7766-249XView further author information
, Bret Tabackd Department of Surgery, Division of Breast Surgery, New York-Presbyterian/Columbia University Medical Center, New York, USAhttps://orcid.org/0000-0003-3440-5316View further author information
, Lee D. Cranmere University of Arizona Cancer Center, Tucson, Az, Usa. Present Affiliation and Contact: Division of Medical Oncology, Department of Medicine, University of Washington Medical Center, and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USAhttps://orcid.org/0000-0002-7789-5442View further author information
, Gregory A Danielsf Division of Hematology-Oncology, University of California San Diego, La Jolla, USAhttps://orcid.org/0000-0001-9087-8009View further author information
, Lawrence Flahertyg Department of Hematology-Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, USAView further author information
, Sigrun Hallmeyerh Department of Hematology-Oncology, Advocate Medical Group, Park Ridge, USAhttps://orcid.org/0000-0001-5342-2846View further author information
, Mohammed Milhemi Section of Oncology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, USAhttps://orcid.org/0000-0003-4663-6824View further author information
, Lynn Feunj Department of Medical Oncology, University of Miami Health System, Miami, USAhttps://orcid.org/0000-0002-7310-2601View further author information
, Ralph Haukek Nebraska Cancer Specialists, Omaha, USAhttps://orcid.org/0000-0002-0243-7279View further author information
, Gary Doolittlel Division of Medical Oncology, Department of Medicine, University of Kansas Medical Center, Kansas City, USAhttps://orcid.org/0000-0002-9141-449XView further author information
, Nancy Gregorym Clinigen Group, Yardley, USAView further author information
& Sapna Patela Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas Md Anderson Cancer Center, Houston, USACorrespondence[email protected]
https://orcid.org/0000-0003-1339-1517View further author information
show allhttps://orcid.org/0000-0003-1339-1517View further author information
Article: 1984059
|
Received 28 Jun 2021, Accepted 20 Sep 2021, Published online: 09 Oct 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.